| 臺大學術典藏 |
2018-09-10T06:12:56Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn, R.M. and Zhang, Y.-J. and Wang, L.-Y. and Chen, C.-J. and Lee, P.-H. and Lee, C.-S. and Tsai, W.-Y. and Santella, R.M.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:43:22Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn R.M.; Zhang Y.-J.; Wang L.-Y.; Chen C.-J.; PO-HUANG LEE; Lee C.-S.; Tsai W.-Y.; Santella R.M.; Lunn R.M.;Zhang Y.-J.;Wang L.-Y.;Chen C.-J.;Po-Huang Lee;Lee C.-S.;Tsai W.-Y.;Santella R.M. |
| 國立暨南國際大學 |
2012 |
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
|
余長澤; Yu, CTR |
| 國立臺北護理健康大學 |
1993-11 |
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer
|
Esrig, D;Spruck, CH;Nichols, PW;Chaiwun, B;Steven, K;Groshen, S;Chen, S-C;Skinner, DG;Jones, PA;Cote, RJ |
| 國立臺灣大學 |
2004 |
P53 Overexpression and Mutation in Metaplastic Carcinoma of the Breast: Genetic Evidence for a Monoclonal Origin of Both the Carcinomatous and the Heterogeneous Sarcomatous Components
|
連晃駿; 林中梧; 毛翠蓮; 郭頌鑫; 蕭正祥; 黃俊升; LIEN, HUANG-CHUN; LIN, CHUNG-WU; MAO, TSUI-LIEN; KUO, SUNG-HSIN; HSIAO, CHENG-HSIANG; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2004-10 |
p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, HC; Lin, CW; Mao, TL; Kuo, SH; Hsiao, CH; Huang, CS: |
| 臺大學術典藏 |
2018-09-10T04:46:16Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, H.-C. and Lin, C.-W. and Mao, T.-L. and Kuo, S.-H. and Hsiao, C.-H. and Huang, C.-S.; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHUNG-WU LIN; HUANG-CHUN LIEN |
| 臺大學術典藏 |
2020-03-03T03:36:54Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Chung-Wu Lin;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; CHUNG-WU LIN; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-05T05:51:25Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Huang-Chun Lien;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; HUANG-CHUN LIEN; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-07T06:48:26Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Tsui-Lien Mao;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:35Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Chiun-Sheng Huang; Lien H.-C.; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-05T12:32:57Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2021-02-23T08:26:44Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Sung-Hsin Kuo;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; Mao T.-L.; SUNG-HSIN KUO; Hsiao C.-H.; Huang C.-S. |
| 國立臺灣大學 |
2002 |
P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection
|
梁金銅; 黃國晉; 鄭永銘; 許輝吉; 鄭安理; 徐志宏; 葉坤輝; 王世名; 張金堅; LIANG, JIN-TUNG; HUANG, KUO-CHIN; JENG, YUNG-MING; HSU, HEY-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; WANG, SHIH-MING; CHANG, KING-JEN |
| 臺大學術典藏 |
2020-04-28T07:25:39Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Chih-Hung Hsu;Yeh K.-H.;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; CHIH-HUNG HSU; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-28T01:06:53Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-14T03:09:20Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; KUO-CHIN HUANG; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-05-03T02:21:22Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
JIN-TUNG LIANG; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2022-08-12T06:28:26Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; KING-JEN CHANG |
| 高雄醫學大學 |
2011 |
p53 peptide prevents LITAF-induced TNF-alpha-mediated mouse lung lesions and endotoxic shock.
|
Tang, X;O'Reilly, A;Asano, M;Merrill, JC;橫山一成;Amar, S. ; Tang, X;O'Reilly, A;Asano, M;Merrill, JC;Yokoyama, KK;Amar, S. |
| 臺北醫學大學 |
1998 |
p53 point mutation enhanced by hepatic regeneration in aflatoxin B1-induced rat liver tumors and preneoplastic lesions.
|
朱娟秀; Lee CC; Liu JY; Lin JK; Chu JS and Shew JY |
| 亞洲大學 |
2011 |
p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through regulating miRNAs
|
;Liu, M.;Chen, C-T.;Yu, D.;洪明奇;Hung, Mien-Chie |
| 國立臺灣大學 |
2016 |
p53 及 ΔNp63α 對 CTEN 基因表現的調控
|
陳雅琪; Chen, Ya-chi |
| 國立成功大學 |
2022-07-29 |
p53 和 Sp1 在雌激素調控的肺癌發展所扮演之角色
|
陳詠晴; Chen, Yung-Ching |
